Tomoko Eto

Title: Tomoko Eto: Innovator in Sustained-Release Pharmaceutical Compositions

Introduction

Tomoko Eto is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release compositions that enhance the efficacy of therapeutic proteins and peptides.

Latest Patents

Eto holds a patent for a "Zinc-containing sustained-release composition, its preparation, and method for producing the same." This innovative composition is designed to stabilize physiologically active proteins or peptides, such as G-CSF, through a simple and high-yield production method. The composition is capable of retaining drug efficacy for several days in a living body due to its sustained releasability. The method involves forming a precipitate by mixing a physiologically active protein or peptide with a water-soluble zinc salt, along with a water-soluble carbonate and/or phosphate aqueous solution.

Career Highlights

Tomoko Eto is currently associated with LTT Bio-pharma Co., Ltd., where she continues to advance her research and development efforts in the pharmaceutical industry. Her work focuses on creating innovative solutions that improve drug delivery and therapeutic outcomes.

Collaborations

Eto collaborates with notable colleagues, including Michio Kimura and Yutaka Mizushima, to further enhance the impact of her research in the field of pharmaceuticals.

Conclusion

Tomoko Eto's contributions to the development of zinc-containing sustained-release compositions exemplify her commitment to advancing pharmaceutical science. Her innovative work has the potential to significantly improve the efficacy of therapeutic treatments.